alexa Kala-Azar is a Neglected Tropical Disease | Open Access Journals
ISSN: 2155-9937
Journal of Molecular Imaging & Dynamics
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Kala-Azar is a Neglected Tropical Disease

Sujit K Bhattacharya1*, Aditya P Dash2 and Probhat Sinha3

1Glocal Hospital, Krishnanagore, West Bengal, India

2Central University of Tamil Nadu, India

3Rajendra Memorial Research Institute of Medical Science, Patna, India

*Corresponding Author:
Sujit K Bhattacharya
Glocal Hospital, Krishnanagore, West Bengal, India
Tel: 8697462003
E-mail: [email protected]

Received date: November 12, 2016; Accepted date: November 13, 2016; Published date: November 16, 2016

Citation: Bhattacharya SK, Dash AP, Sinha P (2016) Kala-Azar is a Neglected Tropical Disease. J Mol Imag Dynamic 6:i107. doi:10.4172/2155-9937.1000i107

Copyright: © 2016 Bhattacharya SK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Molecular Imaging & Dynamics

Abstract

Visceral Leishmaniasis or Kala-azar is prevalent in many countries worldwide. The disease is one of the neglected tropical diseases (NTD). The symptoms and signs of the disease include prolonged fever, loss of weight, anaemia, and liver and spleen enlargements. In the Indian Sub-continent, India, Bangladesh and Nepal are highly endemic for Kala-azar.

Keywords

Visceral Leishmaniasis; Kala-azar; Spleen

Case History

Visceral Leishmaniasis or Kala-azar is prevalent in many countries worldwide. The disease is one of the neglected tropical diseases (NTD). The symptoms and signs of the disease include prolonged fever, loss of weight, anaemia, and liver and spleen enlargements. In the Indian Sub-continent, India, Bangladesh and Nepal are highly endemic for Kala-azar. It was also recently reported from Bhutan. Majority of patients who are not treated with effective drug die. Stibogluconate was the sheet anchor of effective drug for the treatment of Kala-azar. Currently, the drug is ineffective due development of drug resistance and the patient may also die due to its cardio-toxicity. The first oral drug (Miltefosine) for the treatment of Visceral Leishmaniasis has been developed in India in collaboration with Zentaris in Germany (Figure 1). This drug is highly effective in the treatment of VL. Soon after this oral drug development, Paromomycin, an injectable drug was developed; this drug is also highly effective in the treatment of VL. Amphotericin B, an anti-fungal drug is useful against VL. The most effective and safe drug against VL is single dose of lipid amphotericin B. India, Bangladesh and Nepal undertook elimination of Kala-azar from these countries in 2005. This activity brought down the number of Kala-azar cases from the three countries. This programme is a poverty elimination programme.

molecular-imaging-dynamics-child-suffering

Figure 1: A child suffering from Kala-azar (Liver and spleen enlarged).

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

  • 2nd International Conference on Nuclear Medicine & Radiation Therapy
    July 27-28, 2017 Rome, Italy
  • 5th International Conference on Current Trends in Mass Spectrometry
    September 25-27, 2017 Atlanta, USA
  • 8th Global Mass Spectrometry Congress
    Dec 14-16, 2017 Dubai, UAE

Article Usage

  • Total views: 375
  • [From(publication date):
    December-2016 - Jun 26, 2017]
  • Breakdown by view type
  • HTML page views : 328
  • PDF downloads :47
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords